[/C O R R E C T I O N -- JinkoSolar Holding Co., Ltd./ In the news release, JinkoSolar Updates Third Quarter and Full Year 2011 Guidance, issued 14-Nov-2011 by JinkoSolar Holding Co., Ltd. over PR Newswire, we are advised by the company that under the second set of bullet points, the first bullet should read, "Total solar module]
[Contact Information Ida Yu Investor Relations Manager Tel: 86 (21) 6195 9561 ir@htinns.com Email: http://ir.htinns.com China Lodging Group, Limited Reports Third Quarter of 2011 Financial Results 1 , exceeding the high end of the guidance previously announced Net Revenues increased 23.8% year-over-year for the third quarter to RMB626.7 million (US$98.3 million) Adjusted EBITDA from operating hotels (non-GAAP) was]
[JinkoSolar Updates SHANGHAI, November 14, 2011 - For the third quarter of 2011, the Company expects: · Total solar module shipments to be approximately 210 MW – 220 MW, which compares with the Company’s previous guidance of 230 MW – 250 MW; · Total revenues to be in approximately US$270 – US$280 million, which compares with the Company’s previous guidance]
[FORM 10-Q (Mark One) x September 30, 2011 For the quarterly period ended: Or ¨ For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, INC. Maryland 20-8747899 (State or other jurisdiction of incorporation of origination) (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 (Zip code) 011-86-29-33686638 (Former name, former] [CERTIFICATION I, Ronghua Wang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION I, Zack Pan, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Ronghua Wang Chief Executive Officer EX-32.1 4 ex32-1.htm] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Zack Pan Chief Financial Officer (Principal Financial and Accounting Officer) EX-32.2 5 ex32-2.htm]
[JinkoSolar Updates SHANGHAI, November 14, 2011 - For the third quarter of 2011, the Company expects: · Total solar module shipments to be approximately 210 MW – 220 MW, which compares with the Company’s previous guidance of 230 MW – 250 MW; · Total revenues to be in approximately US$270 – US$280 million, which compares with the Company’s previous guidance]
[FORM 10-Q (Mark One) x September 30, 2011 For the quarterly period ended: Or ¨ For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, INC. Maryland 20-8747899 (State or other jurisdiction of incorporation of origination) (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 (Zip code) 011-86-29-33686638 (Former name, former] [CERTIFICATION I, Ronghua Wang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION I, Zack Pan, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Ronghua Wang Chief Executive Officer EX-32.1 4 ex32-1.htm] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Zack Pan Chief Financial Officer (Principal Financial and Accounting Officer) EX-32.2 5 ex32-2.htm]
[CHINARD BLOODRPORATION (Incorporated in theyman Islands with limited liability) (NYSE Ticker:) th 48 1 Garden Road Central Hong KongR. NOTICE OF ANNUAL GENERAL MEETING to Be Held on December 19, 2011 (or anyjourned or postponed meeting thereof) To the Shareholders of Chinard Bloodrporation]
[SCHEDULE 14A INFORMATION o Check the appropriate box: o Preliminary Proxy Statement o Definitive Proxy Statement o Definitiveditional Materials o CHINA PHARMAS, Payment of Filing Fee (Check the appropriate box): No fee required. o Feemputed on table below per Exchange Act Rules14a-6(i)(1) and 0-11. (1) Title of each class of securities to which transaction applies:]
[] [CERTIFICATION I, Lei Liu, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of China Jo-Jo Drugstores, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION I, Ming Zhao, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of China Jo-Jo Drugstores, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Lei Liu Chief Executive Officer] [CERTIFICATION (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Ming Zhao Chief Financial Officer (Principal Financial and Accounting Officer)]
[SINA Reports Third Quarter 2011 Financial Results SHANGHAI, ChinaNovember 8, 2011 SINA Corporation (NASDAQ GS: SINA), a leading online media company and mobile value-added service (MVAS) provider serving China and the global Chinese communities, today announced its unaudited financial results for the third quarter ended September 30, 2011. Third Quarter 2011 Highlights · Net revenues grew 20% year over year] [FORM 6-K November 2011 SINA Corporation 37F, Jin Mao Tower 88 C entury B oulevard, P udong 121 , China Form 20-F x Form 40-F o o o TABLE OF CONTENTS]
